Several cytokines, such as IL‐1β, IL‐6, or tumor necrosis factor alpha (TNFα), have been proven to contribute to proliferation, blast survival, resistance to treatment, and prognosis in acute myeloid leukemia (AML).1, 2, 3, 4. The gene discussed is TNF; the disease is acute myeloid leukemia.